phone iconPhone: (401) 822-4673
phone iconFax: (401) 822-4676
Receive our Health e-Newsletter

News for Healthier Living

Liver-Directed Treatment Is Associated with Improved Survival and Increased Response to Immune Checkpoint Blockade in Metastatic Uveal Melanoma: Results From a Retrospective Multicenter Trial

Researchers from Friedrich-Alexander-University Erlangen-Nurnberg (FAU), et al. have published a paper, in which they analyzed 182 metastatic uveal melanoma patients treated with ICB. The study found cohort A had longer median OS, better PFS trend, and higher ICB response rates, suggesting LDT+ICB may benefit these patients.

September 3, 2025


September 17 2025

September 16 2025

September 15 2025

September 14 2025

September 13 2025

September 12 2025

September 11 2025

September 10 2025

September 9 2025

September 8 2025

September 7 2025

September 6 2025

September 5 2025

September 4 2025

Angell Street Psychiatry
Copyright 2025 HealthBanks, Inc. All rights reserved.
Terms of Use | Privacy Policy